NOT KNOWN DETAILS ABOUT BMS-986141

Pharmacological inhibition of the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; generally known as FRAP-relevant protein (FRP1)) has emerged as being a promising technique for cancer treatment that exploits synthetic lethal interactions with proteins linked to DNA harm maintenance, overcomes resistance to other therap